South and Central America Compression Therapy Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The South and Central America Compression Therapy Market size is expected to reach US$ 140.5 Million by 2034 from US$ 102.7 Million in 2025. The market is estimated to record a CAGR of 3.6% from 2026 to 2034.

Executive Summary and South and Central America Compression Therapy Market Analysis:

The compression therapy market in South & Central America is bolstered by a rising regional burden of noncommunicable diseases (NCDs) and their risk factors, which drive demand for circulatory support and related treatments. Official statistics from the Pan American Health Organization (PAHO) show that NCDs-including cardiovascular disease and diabetes-remain the leading causes of death across the Americas, with deaths from these conditions rising sharply and accounting for the majority of regional mortality in 2025. This heightened disease burden correlates with high rates of obesity and physical inactivity, major contributors to venous disorders and edema that often require compression therapy. Diabetes prevalence in South & Central America is also increasing, with around 35 million adults living with diabetes in 2024, and projections indicating continued rises through 2025, exacerbating complications such as peripheral vascular disease that benefit from compression care. Government led public health initiatives have focused on strengthening primary care for NCDs and expanding prevention, early diagnosis, and management, reflecting official responses to chronic disease trends. Simultaneously, medical technology advancements have introduced more effective and comfortable compression garments and pneumatic devices that improve patient adherence and broaden clinical use beyond venous insufficiency to include lymphedema, post-surgical rehabilitation, and chronic wound support. These official health trends, coupled with product innovation and expanding healthcare access, underpin growth in the compression therapy market across South and Central America.

South & Central America Compression Therapy Market: Strategic Insights

South and Central America Compression Therapy Market Segmentation Analysis:

• By Product, the South and Central America Compression Therapy Market is segmented into Compression Bandages, Compression Wraps, Compression Stockings, Compression Sleeves, Compression Tape, Compression Braces, Compression Pumps, and Others. The Compression Bandages segment dominated the market in 2025.
• By Technology, the South and Central America Compression Therapy Market is segmented into Static Compression Therapy and Dynamic Compression Therapy. The Static Compression Therapy segment dominated the market in 2025.
• By Application, the South and Central America Compression Therapy Market is segmented into Lymphedema, Leg Ulcer, Deep Vein Thrombosis, Varicose Veins, Lipedema, and Others. The Varicose Veins segment dominated the market in 2025.
• By End User, the South and Central America Compression Therapy Market is segmented into Hospitals and Clinics, Nursing Care Centers, Home Care Settings, and Other End Users. The Hospitals and Clinics segment dominated the market in 2025.

South & Central America Compression Therapy Market Players Density: Understanding Its Impact on Business Dynamics

The South & Central America Compression Therapy Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

South and Central America Compression Therapy Market Outlook

Across South America, healthcare reforms aimed at expanding universal health coverage and improving management of chronic diseases present promising opportunities for compression therapy. Countries such as Brazil, Colombia, Chile, and Argentina continue to strengthen public healthcare programs and update clinical protocols for chronic venous disease, wound care, and lymphedema management. As governments seek to reduce the long-term costs associated with venous ulcers, hospitalizations, and disability, reimbursement for evidence-based compression therapy is expected to become more consistent. In parallel, growing private health insurance coverage and increasing awareness among healthcare professionals are likely to support wider adoption of advanced compression products. Improved reimbursement pathways and recognition of compression therapy as a cost-effective intervention are expected to encourage investment in product innovation, clinical training, and broader market penetration across the region.

South and Central America Compression Therapy Market Country Insights

By country, the South and Central America Compression Therapy Market is segmented into Brazil, Argentina, and the Rest of South and Central America. Brazil held the largest share in 2025.

The compression therapy market in Brazil is expanding as Brazil confronts a growing burden of chronic, lifestyle-related health conditions that drive clinical need for circulatory support devices such as compression garments and pneumatic systems. Government health surveillance data show diabetes prevalence rising from 10.2% of adults in 2023, according to the Vigitel survey by the Ministry of Health, elevating risks for peripheral vascular complications where compression therapy is indicated. By 2024, diabetes among adults had climbed further, with 12.9% of the population affected and marked increases in obesity and hypertension noted in official Vigitel 2025 reporting. Obesity, a major risk factor for venous insufficiency and lymphedema, also showed high prevalence. The official Brazilian Ministry of Health surveillance indicates that over 60% of adults had excess weight in 2024, with obesity itself ~25.7%, and national estimates now place about 31-34% of Brazilians as obese. These chronic disease trends increase clinical presentations requiring compression therapy, including venous ulcers and edema. Brazilian public health programs-such as national strategies to combat chronic diseases-are expanding preventive care and rehabilitation services and strengthening primary care infrastructure, which supports wider adoption of compression solutions. Furthermore, regulatory oversight by the Agência Nacional de Vigilância Sanitária (ANVISA) ensures that compression devices are medically regulated and approved for use within Brazil's Unified Health System (SUS), facilitating integration into clinical practice. New product developments, such as advanced ergonomic compression garments and portable pneumatic devices, improve patient adherence in both clinical and home settings, addressing diverse needs beyond traditional venous care to postoperative recovery and chronic wound management. These official public health trends, government initiatives, and technology advancements underpin growth in compression therapy utilization in Brazil during 2023-2025.

South and Central America Compression Therapy Market Company Profiles

Some of the key players operating in the market include Arjo AB, Essity AB, Lohmann & Rauscher GmbH & Co KG, Paul Hartmann AG, Convatec Inc, Enovis Corp, Solventum Corporation, Juzo, SIGVARIS GROUP, and medi Canada Inc

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

South and Central America Compression Therapy Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note:

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise